(Q43842059)

27 November 2017

Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers (English)

1 reference

27 November 2017

1 reference

Daniel Umbricht

1

1 reference

27 November 2017

Rene Koller

series ordinal

2

1 reference

27 November 2017

Franz X Vollenweider

series ordinal

3

1 reference

27 November 2017

Liselotte Schmid

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

27 November 2017

Biological Psychiatry

1 reference

27 November 2017

51

1 reference

27 November 2017

400-406

1 reference

27 November 2017

5

1 reference

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Brain potential evidence for an auditory sensory memory deficit in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of signal probability on sensory evoked potentials in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity (MMN) generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differentiation of negative event-related potentials in an auditory discrimination task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Dissociation of the mismatch negativity and processing negativity attentional waveforms with nitrous oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

N-methyl-D-aspartate enhancement of phasic responses in primate neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of clozapine on auditory event-related potentials in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901242-2

10.1016/S0006-3223(01)01242-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference